D
Sell
2/7/2025Upgraded
Ginkgo Bioworks Holdings, Inc. (DNA) was upgraded to D- from E+ on 2/7/2025 due to an increase in the growth index and valuation index. Earnings per share increased from -$4.2309 to -$1.0801, EBIT increased 66.13% from -$154.28M to -$52.26M, and total revenue increased 58.43% from $56.21M to $89.05M.
E
Sell
3/6/2024Downgrade
Ginkgo Bioworks Holdings, Inc. (DNA) was downgraded to E+ from D- on 3/6/2024 due to a decline in the solvency index and valuation index. The quick ratio declined from 6.6 to 5.88.
D
Sell
7/27/2023Upgraded
Ginkgo Bioworks Holdings, Inc. (DNA) was upgraded to D- from E+ on 7/27/2023 due to an increase in the volatility index and total return index.
E
Sell
3/14/2023Downgrade
Ginkgo Bioworks Holdings, Inc. (DNA) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
Ginkgo Bioworks Holdings, Inc. (DNA) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
Ginkgo Bioworks Holdings, Inc. (DNA) was downgraded to E+ from D- on 2/8/2023 due to a major decline in the solvency index, growth index and total return index. Total revenue declined 54.09% from $144.62M to $66.4M, the quick ratio declined from 11.49 to 11.36, and EBIT declined 0.94% from -$646.91M to -$653.02M.
D
Sell
5/5/2022Upgraded
Ginkgo Bioworks Holdings, Inc. (DNA) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
E
Sell
4/20/2022Downgrade
Ginkgo Bioworks Holdings, Inc. (DNA) was downgraded to E+ from D- on 4/20/2022 due to a decline in the volatility index, total return index and valuation index.
D
Sell
3/30/2022Downgrade
Ginkgo Bioworks Holdings, Inc. (DNA) was downgraded to D- from D on 3/30/2022 due to a substantial decline in the total return index, efficiency index and growth index. EBIT declined 6,361.86% from -$26.07M to -$1.68B, operating cash flow declined 3,062.2% from -$5.24M to -$165.54M, and net income declined 1,471.1% from -$101.88M to -$1.6B.
D
Sell
1/12/2022Downgrade
Ginkgo Bioworks Holdings, Inc. (DNA) was downgraded to D from D+ on 1/12/2022 due to a large decline in the volatility index and total return index.
D
Sell
1/3/2022Downgrade
Ginkgo Bioworks Holdings, Inc. (DNA) was downgraded to D+ from C- on 1/3/2022 due to a decline in the volatility index, valuation index and total return index.
C
Hold
11/3/2021None
Ginkgo Bioworks Holdings, Inc. (DNA) was downgraded to C- from U on 11/03/2021.
